Clinical Trial Update: SeriACL™ Device (Gen IB) Trial for Anterior Cruciate Ligament (ACL) Repair [Phase 1, Phase 2]

View source ↗

Summary

SeriACL device from Serica Technologies completed Phase 1/2 clinical trials for anterior cruciate ligament reconstruction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury

Drugs mentioned

• SeriACL

Snippet

Sponsor: Serica Technologies, Inc. | Conditions: Anterior Cruciate Ligament Reconstruction | Phase 1, Phase 2 | Status: COMPLETED